cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells

Genomics

Volumn 66, Issue 2, 2000, Pages 204-212

  Cmarik, Joan L ^a   Hegamyer, Glenn ^a   Gerrard, Bernard ^a   Dean, Michael ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLECKSTRIN;

ANIMAL CELL; ARTICLE; CANCER; CELL CULTURE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11; DNA SEQUENCE; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC TRANSFORMATION; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TUMOR PROMOTION;

ANIMALIA; MURINAE;

EID: 0034210604     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6210     Document Type: Article

References (54)

1. Abrams C. S., Wu H., Zhao W., Belmonte E., White D., Brass L. F. Pleckstrin inhibits phosphoinositide hydrolysis initiated by G-protein-coupled and growth factor receptors: A role for pleckstrin's PH domains. J. Biol. Chem. 270:1995a;14485-14492.
2. βγ-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinase. J. Biol. Chem. 271:1996a;25192-25196.
3. Abrams C. S., Zhao W., Belmonte E., Brass L. F. Protein kinase C regulates pleckstrin by phosphorylation of sites adjacent to the N-terminal pleckstrin homology domain. J. Biol. Chem. 270:1995b;23317-23321.
4. βγ. Biochim. Biophys. Acta. 1314:1996b;233-238.
5. Al-Aoukaty A., Rolstad B., Maghazachi A. A. Recruitment of pleckstrin and phosphoinositide 3-kinase γ into the cell membranes, and their association with Gβγ after activation of NK cells with chemokines. J. Immunol. 162:1999;3249-3255.
6. Auethavekiat V., Abrams C. S., Majerus P. W. Phosphorylation of platelet pleckstrin activates inositol polyphosphate 5-phosphatase I. J. Biol. Chem. 272:1997;1786-1790.
7. Baier R., Bondeva T., Klinger R., Bondev A., Wetzker R. Retinoic acid induces selective expression of phosphoinositide 3-kinase γ in myelomonocytic U937 cells. Cell Growth Differ. 10:1999;447-456.
8. Bernstein L. R., Bravo R., Colburn N. H. 12-O-Tetradecanoylphorbol-13-acetate-induced levels of AP-1 proteins: A 46-kDa protein immunoprecipitated by anti-Fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells. Mol. Carcinogenesis. 6:1992;221-229.
9. Bernstein L. R., Colburn N. H. AP1/Jun function is differentially induced in promotion-sensitive and -resistant JB6 cells. Science. 244:1989;566-569.
10. Brumell J. H., Craig K. L., Ferguson D., Tyers M., Grinstein S. Phosphorylation and subcellular redistribution of pleckstrin in human neutrophils. J. Immunol. 158:1997;4862-4871.
11. Brumell J. H., Howard J. C., Craig K., Grinstein S., Schreiber A. D., Tyers M. Expression of the protein kinase C substrate pleckstrin in macrophages: Association with phagosomal membranes. J. Immunol. 163:1999;3388-3395.
12. Cmarik J. L., Colburn N. H. Use of mouse JB6 cells to identify molecular targets and novel agents for prevention of carcinogenesis. Ohigashi H. Proceedings of the International Conference on Food Factors: Chemistry and Cancer Prevention. 1997;67-76 Springer-Verlag, Tokyo.
13. Cmarik J. L., Herschman H., Colburn N. H. Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells. Mol. Carcinogenesis. 11:1994;115-124.
14. Cmarik J. L., Li Y., Ogram S. A., Min H., Reeves R., Colburn N. H. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells. Oncogene. 16:1998;3387-3396.
15. Cmarik J. L., Min H., Hegamyer G., Zhan S., Kulesz-Martin M., Yoshinaga H., Matsuhashi S., Colburn N. H. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. USA. 96:1999;14037-14042.
16. Colburn N. H., Bruegge W. F., Bates J. R., Gray R. H., Rossen J. D., Kelsey W. H., Shimada T. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res. 38:1978;624-634.
17. Colburn N. H., Former B. F., Nelson K. A., Yuspa S. H. Tumour promoter induces anchorage independence irreversibly. Nature. 281:1979;589-591.
18. Colburn N. H., Wendel E. J., Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: Mitogen-resistant variants are sensitive to promotion. Proc. Natl. Acad. Sci. USA. 78:1981;6912-6916.
19. Dong Z., Birrer M. J., Watts R. G., Matrisian L. M., Colburn N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA. 91:1994;609-613.
20. Dong Z., Ding M., Ma W.-Y., Colburn N. H. Inhibition of tumor promoter induced transformation by expression of the small GTP-binding protein Rac in JB6 cells. Int. J. Oncol. 11:1997;157-161.
21. Gailani D., Fisher T. C., Mills D. C., Macfarlane D. E. P47 phospho-protein of blood platelets (pleckstrin) is a major target for phorbol ester-induced protein phosphorylation in intact platelets, granulocytes, lymphocytes, monocytes and cultured leukaemic cells: Absence of P47 in non-haematopoietic cells. Br. J. Haematol. 74:1990;192-202.
22. Harlan J. E., Hajduk P. J., Yoon H. S., Fesik S. W. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature. 371:1994;168-170.
23. 1 on the phosphorylation of specific proteins in blood platelets. Biochem. J. 178:1979;397-406.
24. Hu M. H., Bauman E. M., Roll R. L., Yeilding N., Abrams C. S. Pleckstrin 2, a widely expressed paralog of pleckstrin involved in actin rearrangement. J. Biol. Chem. 274:1999;21515-21518.
25. Huang C., Ma W. Y., Dong Z. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol. Cell. Biol. 16:1996;6427-6435.
26. Huang C., Ma W.-Y., Young M. R., Colburn N. H., Dong Z. Shortage of mitogen-activated protein (MAP) kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 P- cells. Proc. Natl. Acad. Sci. USA. 95:1998;156-161.
27. Huang C., Schmid P. C., Ma W. Y., Schmid H. H. O., Dong Z. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J. Biol. Chem. 272:1997;4187-4194.
28. Imaoka T., Lynham J. A., Haslam R. J. Purification and characterization of the 47,000-dalton protein phosphorylated during degranulation of human platelets. J. Biol. Chem. 258:1983;11404-11414.
29. Inazu T., Yamada K., Miyamoto K. Cloning and expression of pleckstrin 2, a novel member of the Pleckstrin family. Biochem. Biophys. Res. Commun. 265:1999;87-93.
30. Kharrat A., Millevoi S., Baraldi E., Ponting C. P., Bork P., Pastore A. Conformational stability studies of the pleckstrin DEP domain: Definition of the domain boundaries. Biochim. Biophys. Acta. 1385:1998;157-164.
31. Lemmon M. A., Ferguson K. M. Pleckstrin homology domains. Curr. Top. Microbiol. Immunol. 228:1998;39-74.
32. Li J.-J., Dong Z., Dawson M. I., Colburn N. H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res. 56:1996;483-489.
33. Li J. J., Rhim J. S., Schlegel R., Vousden K. H., Colburn N. H. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene. 16:1998;2711-2721.
34. Li J. J., Westergaard C., Ghosh P., Colburn N. H. Inhibitors of both NF-κB and AP-1 activation block neoplastic transformation response. Cancer Res. 57:1997;3569-3576.
35. Liang P., Averboukh L., Pardee A. B. Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimization. Nucleic Acids Res. 21:1993;3269-3275.
36. Ma A. D., Abrams C. S. Pleckstrin induces cytoskeletal reorganization via a Rac-dependent pathway. J. Biol. Chem. 274:1999;28730-28735.
37. 2-terminal PH domain. J. Cell. Biol. 136:1997;1071-1079.
38. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet. 15:1997;417-474.
39. Montgomery J. C., Silverman K. A., Buchberg A. M. The 1999 Chromosome Committee reports for the mouse genome: Mouse chromosome 11. Mamm. Genome. 10:1999.
40. Onishi Y., Kizaki H. Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem. Biophys. Res. Commun. 228:1996;7-13.
41. Pennie W. D., Sun Y., Kim H., Colburn N. H. Differential expression of TIMP-3 during neoplastic progression in the mouse JB6 model system. Methods Mol. Biol. 85:1997;249-261.
42. Ponting C. P., Bork P. Pleckstrin's repeat performance: A novel domain in G-protein signaling? Trends Biochem. Sci. 21:1996;245-246.
43. Rowe L. B., Nadeau J. H., Turner R., Frankel W. N., Letts V. A., Eppig J. T., Ko M. S., Thurston S. J., Birkenmeier E. H. Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm. Genome. 5:1994;253-274.
44. Sano K., Takai Y., Yamanishi J., Nishizuka Y. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation: Comparison of thrombin and collagen actions. J. Biol. Chem. 258:1983;2010-2013.
45. Schriml L. M., Peterson R., Gerrard B., Dean M. Use of denaturing HPLC to map human and murine genes and to validate SNPs. BioTechniques. 4:2000;740-745.
46. Shibahara K., Asano M., Ishida Y., Aoki T., Koike T., Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene. 166:1995;297-301.
47. Stoyanova S., Bulgarelli-Leva G., Kirsch C., Hanck T., Klinger R., Wetzker R., Wymann M. P. Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase γ: Structure-activity analysis and interactions with wortmannin. Biochem. J. 324:1997;489-495.
48. Sun Y., Hegamyer G., Colburn N. H. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: One is homologous to human tissue inhibitor of metallo-proteinases-3. Cancer Res. 54:1994;1139-1144.
49. Sun Y., Hegamyer G., Kim H., Sithanandam, Li H., Watts R., Colburn N. H. Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 (mTIMP-3) and its promoter: Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation. J. Biol. Chem. 270:1995;19312-19319.
50. Takahashi K., Heine U. I., Junker J. L., Colburn N. H., Rice J. M. Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. Cancer Res. 46:1986;5923-5932.
51. Tyers M., Rachubinski R. A., Stewart M. I., Varrichio A. M., Shorr R. G. L., Haslam R. J., Harley C. B. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 333:1988;470-473.
52. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
53. Watts R. G., Huang C., Young M. R., Li J. J., Dong Z., Pennie W. D., Colburn N. H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 17:1998;3493-3498.
54. Young M. R., Li J. J., Rincon M., Flavell R. A., Sathyanarayana B. K., Hunziker R., Colburn N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA. 96:1999;9827-9832.